Histopathologic assessment of pancreatic cancer: Does one size fit all?

Reid M. D., Bagci P., Adsay N. V.

JOURNAL OF SURGICAL ONCOLOGY, cilt.107, sa.1, ss.67-77, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 107 Sayı: 1
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1002/jso.23194
  • Dergi Adı: JOURNAL OF SURGICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.67-77
  • Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

Most solid pancreatic tumors are invasive ductal adenocarcinoma (PDAC). Because PDAC is the most common tumor, it has become synonymous with the term Pancreas Cancer. However, other malignant neoplasms occur in the pancreas (acinar, neuroendocrine and colloid carcinomas, and metastases) all with different outcomes. Because these tumors are often combined with PDAC in research databases, it causes misleading variability in the analysis of pancreatic cancers. We examine the histopathology of a variety of pancreatic cancers. J. Surg. Oncol. 2013;107:6777. (c) 2012 Wiley Periodicals, Inc.